FDA device listing
Qbiosens Qcsl Cell Separation and Lysis Device
FDA device listing 1086491978 · STS Corporation
Key facts
| Proprietary names | Qbiosens Qcsl Cell Separation and Lysis Device |
|---|---|
| Owner/operator | STS Corporation |
| Owner/operator number | 10056102 |
| Product codes | NZB |
| Device names | NZB - Quality Control Material, Genetics, Dna |
| Device class | Class II |
| Classification regulations (21 CFR) | 866.5910 |
| Review panels | Microbiology |
| Registered establishments | STS CORPORATION |
| Establishment registrations | 3014150341 |
| FEI numbers | 3014150341 |
| Establishment operations | Complaint File Establishment, Repackager/Relabeler, Specification Developer |
| Registration valid through | 2026 |
At a glance
- 1–9 Registered establishments listing this device
- None listed Premarket submission listed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA device listings
Establishments that make or process devices for the U.S. market must list each device with the FDA. A listing records the device's proprietary names, product codes and premarket submission, and every registered establishment that handles it.
Source: U.S. Food and Drug Administration (FDA), Establishment Registration and Device Listing database